TapewireFind a company

person · Reporting owner

EHRLICH JASON

Disclosed activity across 1 company

Tapewire entity
111881
SEC CIK
0001754049

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Kodiak Sciences Inc.KOD · Entity 4388See RemarksJune 24, 2023June 27, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Kodiak Sciences Inc.

Report date June 24, 2023 · Filed June 27, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.24 · Expires 2033-06-23Direct207,500 Reported balance After 2023-06-24 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2023-06-24 · Grant · Acquired 207,500 · Balance 207,500

F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 24, 2023 Filed Jun 27, 2023 21:35 UTC Kodiak Sciences Inc. KOD · Entity 4388 GrantStock Option (Right to Buy) · Derivative 207,500 $0.00 Strike: $7.24 $0.00
Disclosure

SEC source: 0001209191-23-039944 · doc4.xml · derivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,500

Underlying: Common Stock · 207,500 shares

Expires 2033-06-23

F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 16, 2023 Filed Jun 17, 2023 00:27 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 2,258 $9.23 $20,841.34
Disclosure

SEC source: 0001209191-23-038166 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,924

F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2023. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
June 15, 2023 Filed Jun 17, 2023 00:27 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionRestricted Stock Units · Derivative 1,875 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-038166 · doc4.xml · derivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 1,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock.

F5 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

F5 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 15, 2023 Filed Jun 17, 2023 00:27 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionRestricted Stock Units · Derivative 3,619 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-038166 · doc4.xml · derivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,619

Underlying: Common Stock · 3,619 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock.

F4 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

F4 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 15, 2023 Filed Jun 17, 2023 00:27 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 5,494 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-038166 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,182

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock.

Read SEC document
June 14, 2023 Filed Jun 17, 2023 00:27 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,132 $9.42 $10,663.44
Disclosure

SEC source: 0001209191-23-038166 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,688

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units ("RSU") on June 11, 2023. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
June 11, 2023 Filed Jun 13, 2023 21:33 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionRestricted Stock Units · Derivative 2,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-036830 · doc4.xml · derivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,900

Underlying: Common Stock · 2,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

F2 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

F2 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 11, 2023 Filed Jun 13, 2023 21:33 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 2,900 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-036830 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,820

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

Read SEC document
July 06, 2022 Filed Jul 8, 2022 21:23 UTC Kodiak Sciences Inc. KOD · Entity 4388 GrantStock Option (Right to Buy) · Derivative 142,500 $0.00 Strike: $8.15 $0.00
Disclosure

SEC source: 0001209191-22-041689 · doc4.xml · derivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,500

Underlying: Common Stock · 142,500 shares

Expires 2032-07-05

F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 17, 2022 Filed Jun 17, 2022 23:56 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 2,282 $7.02 $16,019.64
Disclosure

SEC source: 0001209191-22-038181 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,920

F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2022. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
June 15, 2022 Filed Jun 17, 2022 23:56 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionRestricted Stock Units · Derivative 1,875 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-038181 · doc4.xml · derivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,625

Underlying: Common Stock · 1,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

F5 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

F5 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 23:56 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionRestricted Stock Units · Derivative 3,619 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-038181 · doc4.xml · derivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,238

Underlying: Common Stock · 3,619 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

F4 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

F4 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 23:56 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,205 $7.21 $8,688.05
Disclosure

SEC source: 0001209191-22-038181 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,202

F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 11, 2022. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).

Read SEC document
June 15, 2022 Filed Jun 17, 2022 23:56 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 5,494 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-038181 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,407

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

Read SEC document
June 11, 2022 Filed Jun 15, 2022 00:32 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionRestricted Stock Units · Derivative 2,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-036834 · doc4.xml · derivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,800

Underlying: Common Stock · 2,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

F3 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

F3 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
June 11, 2022 Filed Jun 15, 2022 00:32 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 2,900 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-036834 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,913

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.

F2 · balance_after: Includes (i) 73 shares acquired under the 2018 Employee Stock Purchase Plan ("ESPP") on November 30, 2021 and (ii) 399 shares acquired under the ESPP on May 31, 2022.

Read SEC document
February 16, 2022 Filed Feb 18, 2022 22:14 UTC Kodiak Sciences Inc. KOD · Entity 4388 GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $131.44 $0.00
Disclosure

SEC source: 0001209191-22-011374 · doc4.xml · derivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2031-02-20

F1 · derivative.exercise_date: On February 21, 2021, the Reporting Person was awarded a performance-based option. 1/4th of the shares subject to the option vested on February 16, 2022 upon the achievement of certain performance criteria (the "Performance Criteria Achievement Date"); thereafter, the shares subject to the option will vest in thirty-six (36) successive equal monthly installments measured from the Performance Criteria Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 22:17 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 6,950 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-22-004636 · doc4.xml · derivative · entry 7

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 218,538

Underlying: Common Stock · 6,950 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 22:17 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 198 $66.91 $13,249.13
Disclosure

SEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 6

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,541

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $66.91 to $66.99, inclusive.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 22:17 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 533 $66.28 $35,328.89
Disclosure

SEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,739

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $65.85 to $66.41, inclusive.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 22:17 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 2,995 $65.00 $194,688.78
Disclosure

SEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,272

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $64.395 to $65.33, inclusive.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 22:17 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 2,416 $63.55 $153,546.71
Disclosure

SEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,267

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $63.135 to $64.11, inclusive.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 22:17 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 808 $62.72 $50,680.35
Disclosure

SEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,683

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $62.02 to $62.98, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 22:17 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 6,950 $10.29 $71,515.50
Disclosure

SEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 21:35 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 6,950 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-21-070934 · doc4.xml · derivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,488

Underlying: Common Stock · 6,950 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 21:35 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,709 $88.51 $151,269.57
Disclosure

SEC source: 0001209191-21-070934 · doc4.xml · nonDerivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,541

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $88.13 to $89.01, inclusive.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 21:35 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 3,709 $87.60 $324,890.60
Disclosure

SEC source: 0001209191-21-070934 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,250

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $87.06 to $88.035, inclusive.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 21:35 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,532 $86.60 $132,670.59
Disclosure

SEC source: 0001209191-21-070934 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,959

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $86.085 to $87.025, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 21:35 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 6,950 $10.29 $71,515.50
Disclosure

SEC source: 0001209191-21-070934 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:55 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 6,950 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-21-066813 · doc4.xml · derivative · entry 7

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,438

Underlying: Common Stock · 6,950 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:55 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 106 $101.21 $10,728.26
Disclosure

SEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 6

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,541

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $101.17 to $101.27, inclusive.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:55 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,071 $100.44 $107,571.24
Disclosure

SEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,647

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $100.155 to $101.095, inclusive.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:55 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,881 $99.57 $187,291.17
Disclosure

SEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,718

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $99.12 to $100.08, inclusive.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:55 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 3,701 $98.63 $365,029.63
Disclosure

SEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,599

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $98.06 to $99.04, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:55 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 191 $96.82 $18,492.62
Disclosure

SEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,300

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:55 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 6,950 $10.29 $71,515.50
Disclosure

SEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 20:52 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 6,950 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-21-061375 · doc4.xml · derivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,388

Underlying: Common Stock · 6,950 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 20:52 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 1,252 $112.73 $141,143.59
Disclosure

SEC source: 0001209191-21-061375 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,541

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $112.23 to $113.16, inclusive.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 20:52 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 5,698 $111.56 $635,680.85
Disclosure

SEC source: 0001209191-21-061375 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,793

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $111.16 to $112.04, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 20:52 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 6,950 $10.29 $71,515.50
Disclosure

SEC source: 0001209191-21-061375 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 21:02 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 6,950 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-21-057278 · doc4.xml · derivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,338

Underlying: Common Stock · 6,950 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 21:02 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 349 $101.31 $35,356.95
Disclosure

SEC source: 0001209191-21-057278 · doc4.xml · nonDerivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,541

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $101.175 to $101.94, inclusive.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 21:02 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 503 $100.52 $50,563.82
Disclosure

SEC source: 0001209191-21-057278 · doc4.xml · nonDerivative · entry 3

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,890

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $100.14 to $100.96, inclusive.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 21:02 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 6,098 $99.74 $608,243.18
Disclosure

SEC source: 0001209191-21-057278 · doc4.xml · nonDerivative · entry 2

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,393

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $99.095 to $100.08, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 21:02 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionCommon Stock 6,950 $10.29 $71,515.50
Disclosure

SEC source: 0001209191-21-057278 · doc4.xml · nonDerivative · entry 1

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 Exercise / conversionStock Option (Right to Buy) · Derivative 5,258 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001209191-21-053158 · doc4.xml · derivative · entry 8

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,288

Underlying: Common Stock · 5,258 shares

Expires 2028-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 23 $93.04 $2,139.92
Disclosure

SEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 7

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,541

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 2,278 $92.52 $210,764.66
Disclosure

SEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 6

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,564

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $92.02 to $92.995, inclusive.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 3,193 $91.60 $292,463.47
Disclosure

SEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 5

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,842

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $91.10 to $91.995, inclusive.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 20:59 UTC Kodiak Sciences Inc. KOD · Entity 4388 SaleCommon Stock 542 $90.64 $49,128.24
Disclosure

SEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 4

EHRLICH JASON · CIK 0001754049 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,035

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $89.945 to $90.94, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.